Abstract
Melasma is a complex multifactorial pathology of skin pigmentation with increased deposits of melanin with or without vascular alterations. Many light platforms have been used alone and in combination with topical agents. In this research we found that IPL was combined with oral and topicals to target both melanin and hemoglobin components. However, the efficacy of one or another treatment combination is unknown. The purpose of this systematic review is to evaluate the efficacy of the use of IPL as a single or combined strategy in the treatment of Melasma. A systematic search was carried out in Pub Med, Science Direct and Cochrane, from March to May 2020, a total of 354 articles were obtained, which when applying selection filters, inclusion and exclusion criteria, left 10. The selected articles were Green and Britten's Evidence Categorization and Strength Rating scales applied.The sample consisting of 10 articles gathers 355 patients, 98.8% were female, and of high phototype, 10.7% treated with IPL alone, 37.5% combined with laser and 51.8% with topical or oral depigmenting agents. The IPL is a device that has a modest effect in the treatment of Melasma. Using the IPL combined with lasers reduced the MASI by around 60%, and the combination with topical or oral depigmenting agents by about 40%. The IPL plus laser combination is the most effective combination, especially if the laser is in Q-Switched combination, in the treatment of Melasma.
References
Godec O, Elbuluk N. Melasma: An Up-to-date comprehensive review. Dermatol Ther. [revista on-line]. 2017[consultado en enero 12 2020]; 7:305-318. Disponible en: DOI: 10.1007/s13555-017-0194-1.
Yi, J., Hong, T., Zeng, H., Li, P., Li, P., Wang, S et al. A Meta-analysis-based assessment of intense pulsed light for treatment of Melasma. Aesth Plast Surg. [Revista on-line]. 2020 [consultado en mayo 10 de 2020]; Disponible en:.Doi: 10.1007 / s00266-020-01637-x
Tong LG, Wu Y, Wang B, Xu XG, Tu H D, Chen HD, Li YH. Combination of fractional QSLR and IPL form melasma treatment in chinese population. JCLT. 2016. Sept 07. [Epub ahead of ptint]. Disponible en: doi: 10.1080 / 14764172.2016.1228980
Chung JY, Lee JH, Lee JH. Topical tranexamic acid as an adjuvant treatment in melasma: side-by-side comparison clinical study. Jour Dermatol Treat. 2015 [Epub ahead of print]. Disponible en: https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01177405/
Zoccali G, Piccolo D, Allegra P; Giuliani M. Melasma treated with intense pulsed light. Aesth Plast Surg. [Revista on-line] 2010 [consultado 17 de mayo 2020]; 34(4): 486-493. Disponible en: https://pubmed.ncbi.nlm.nih.gov/20225000/
Jong Yoon Chung, Choi M, Hyung Lee J, Cho S, Lee Hee J. Pulse in pulse intense pulsed light for melasma treatment: a pilot study. Dermatol Surg. [Revista on-line] 2014 [consultado 17 de mayo 2020]; 40: 162-168. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1111/dsu.12414
Vachiramon V, Sirithanabadeekul P, Sahawatwong S. Low Fluence Q-switched Nd-YAG 1064 nm laser and intense pulsed light for the treatment of Melasma. JEADV. [Revista on-line] 2015 [consultado 13 octubre 2019] 29:1339-1346.Disponible en: doi: 10.1111 / jdv.12854
Hassan A M, Elfar N N, Rizk O M, Eissa, N Y. Pulsed dye laser versus intense pulsed light in Melasma: a split/face comparative study. JDT. 2018. Oct 24. [Epub ahead of print]. Disponible: doi: 10.1080 / 09546634.2018.1441487
Goldman MP, Gold MH, Palm MD, Colón LE, Preston N, Johnson LA, Gottschalk RW (2011. Sequential treatment with combination cream and intense pulsed light is more efficacious than sequential treatment with an inactive (control) cream and intense pulsed light in patients with moderate to severe melasma. CD. [Revista on-line] 2011[consultado febrero 12 2020]; 37 (2):224–233. Disponible en: doi: 10.1111 / j.1524-4725.2010. 01849.x
Figueredo S L, Trancoso S S. (2012). Single-session intense pulsed light combined with stable fixed-dose triple combination topical therapy for the treatment of refractory melasma. DT [Revista on-line] 2012 [consultado 15 mayo 2020]; 25(5):477–480. Disponible en: doi:10.1111/j.1529-8019.2012. 01530.x
Cho HH, Choi M, Cho S, Lee JH. Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd:YAG laser. JDT. [Revista on-line] 2012 [consultado 25 febrero 2020]; 24(4): 292-296. Disponible en: DOI: 10.3109/09546634.2011.643220

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright (c) 2023 Revista Iberoaméricana de Láser Médico
